At 6.2% CAGR, Cancer Tissue Diagnostics Market Size will reach 3,419.61 million USD by 2027

(AmericaNewsHour via Comtex)

Market Study Report has released a new research study on Cancer Tissue Diagnostics market Analysis 2019-2027 inclusive of one or more factors covering regional opportunities, application landscape, product demand trends, and end-use portfolio of the industry over the forecast timeframe. The report also outlines the competitive framework of the Cancer Tissue Diagnostics industry detailing the SWOT analysis and market share dominance of the prominent players.

The global cancer tissue diagnostics market is expected to reach US$ 3,419.61 Mn in 2027 from US$ 2,025.41 in 2018. The market is estimated to grow with a CAGR of 6.2% from 2019-2027.

Cancer tissue diagnostic techniques are used to detect the tumor in the malignant tissues. In the last few years, immunohistochemistry (IHC) was used to increase the detection of specific antigens in the tumor tissue. The screening with the help of nonfluorescent chromogens is analyzed with conventional microscopy. There are recent techniques developed for cancer tissue diagnosis. Fluorescence in situ hybridization, the method is used for examination of a specific genetic abnormality in the genome. The hybridized deoxyribonucleic acid (DNA) is examined with particular probes.

Request a sample of this premium report at 

Key Company Profiles

  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Abbott
  • Enzo Biochem Inc.
  • Agilent Technologies, Inc.
  • Cancer Genetics Inc.
  • Merck Kgaa (Sigma-Aldrich)
  • Abcam Plc.
  • Danaher

The high cost of cancer diagnostics may restrain the growth of the market during the forecast period. Factors such as high costs involved in diagnosis as well as treatment have a restraining effect on the cancer tissue diagnostic market. Cancer diagnostics tests have become so pricey that ordinary people are unable to afford it. High out-of-pocket costs are barriers to potentially life-saving diagnosis or life-prolonging treatments. These sums up to high diagnosis cost, and thus, patients delay or avoid the diagnosis, which results as a barrier to treatment. According to the study by Marten group, the average out-of-pocket cost of a diagnostic mammogram can be $234 on average, while a breast MRI can cost patients $1,021 on average. Therefore, market players need to focus on developing new products that more cost-efficient than the existing ones in the market to gain potential growth.

The market for cancer tissue diagnostics is expected to grow, owing to factors such as growing cancer prevalence across the globe, new product launches & FDA approvals and growing investments for tissue diagnostics are boosting the market over the years. In addition, the emerging markets in developing countries are likely to have a positive impact on the growth of the market in the coming years. However, factors such as high cost of cancer diagnostics are likely to have a negative impact on the growth of the market in the coming years.

Global cancer tissue diagnostics market is segmented by test type. On the basis of test type, the market is segmented into immunohistochemical tests and in situ hybridization tests. On the basis of type, immunohistochemical tests are further sub-segmented into breast cancer, colorectal cancer, prostate cancer, stomach cancer, and others. On the basis of type, in situ hybridization tests is further sub-segmented into breast cancer, lung cancer, bladder cancer, and others. In 2018, the breast cancer segment held the largest share in the market, by immunohistochemical tests.

Some of the major primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization, Public Health Agency of Canada, International Agency for Research on Cancer, Canadian Breast Cancer Foundation, National Cancer Institute (NCI), National Institute of Cancer Prevention and Research (NICPR), Pancreatic Cancer Network South Africa, and others.

Request a discount on standard prices of this premium report at


1. Introduction

2. Global Cancer Tissue Diagnostics Market – Key Takeaways

3. Research Methodology

4. Global Cancer Tissue Diagnostics Market – Market Landscape

5. Global Cancer Tissue Diagnostics Market – Key Industry Dynamics

6. Cancer Tissue Diagnostics Market – Global Analysis

7. Global Cancer Tissue Diagnostics Market Analysis- by Test Type

8. Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 – Geographical Analysis

9. Cancer Tissue Diagnostics Market- Industry Landscape

10. Cancer Tissue Diagnostics Market-Key Company Profiles

10.1 Bio-Rad Laboratories, Inc.

10.2 Thermo Fisher Scientific, Inc.

10.3 F. Hoffmann-La Roche Ltd.

10.4 Abbott

10.5 Enzo Biochem Inc.

10.6 Agilent Technologies, Inc.

10.7 Cancer Genetics Inc.

10.8 Merck Kgaa (Sigma-Aldrich)

10.9 Abcam Plc.

10.10 Danaher

11. Appendix

buying decision on this premium report 

About Us: allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:

Market Study Report LLC

4 North Main Street,

Selbyville, Delaware 19975


Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: [email protected]



The post At 6.2% CAGR, Cancer Tissue Diagnostics Market Size will reach 3,419.61 million USD by 2027 appeared first on America News Hour.